• Rotigotine Workflows for Parkinson’s Disease Research

  2026-08-23

  Build reproducible Rotigotine experiments around receptor pharmacology, oxidative-stress readouts, and nose-to-brain formulation comparisons. This practical guide connects SH-SY5Y cell assays with haloperidol-based behavioral models while emphasizing vehicle control, nanoparticle quality, and translational limits.

• Perphenazine Workflows for D2 and Host Defense

  2026-08-22

  Perphenazine combines dopamine D2 receptor antagonism with a broad phenothiazine receptor profile, enabling coordinated neuropharmacology, mitochondrial stress, and host-directed antibacterial studies. This workflow-focused guide shows how to control solvent effects, distinguish receptor biology from cytotoxicity, and translate ROS–autophagy findings into reproducible assays.

• MMAE and Cancer Cell Plasticity

  2026-08-21

  Monomethyl auristatin E (MMAE) is more than a potent cytotoxic reagent: in an antibody-drug conjugate, it can convert tumor-selective recognition into a mechanistically defined mitotic endpoint. This article connects MMAE strategy with evidence on EBV-driven plasticity in nasopharyngeal carcinoma, while distinguishing established findings from translational hypotheses.

• RG7388: Applied MDM2 Antagonist Workflows

  2026-08-20

  RG7388 offers a practical route to reactivate p53 in wild-type p53 cancer models, from biochemical binding assays to oral xenograft studies. This guide connects selective MDM2 inhibition with biomarker-aware chemoradiotherapy experiments, combination testing, and troubleshooting.

• Phenothiazines Strengthen Macrophage Antibacterial Defense

  2026-08-20

  Qiu et al. show that phenothiazines enhance macrophage control of intracellular bacteria by increasing reactive oxygen species, lysosomal activity, and autophagy. The study positions host-directed phenothiazine activity as a mechanistically testable strategy against intracellular infection, while also identifying important limits for translation beyond the infection model.

• VER 155008: HSP 70 Inhibitor Mechanism

  2026-08-19

  VER 155008 is an adenosine-derived HSP 70 inhibitor that targets the ATPase pocket of Hsp70-family chaperones. Product information reports biochemical Hsp70 inhibition at 0.5 μM and cellular growth-inhibition values of 5.3–14.4 μM in selected cancer cell lines, while mouse tumor exposure was limited.

• Sodium Oxamate: Practical LDH-A Workflows

  2026-08-19

  Sodium Oxamate enables controlled disruption of lactate production without introducing DMSO or ethanol into aqueous assays. This guide translates a neuroinflammation study into practical metabolic, lactylation, cancer-cell, and white-matter injury workflows, with numeric starting conditions and troubleshooting guidance.

• Perphenazine: D2 Antagonist Research Guide

  2026-08-18

  Perphenazine is a dopamine D2 receptor antagonist with a broader phenothiazine receptor binding profile. Research data support its use in schizophrenia research, mitochondria-mediated cell death induction, opioid tolerance suppression models, and emerging host-directed antibacterial studies.

• SAR405: Selective Vps34 Inhibitor for Autophagy

  2026-08-18

  SAR405 is a potent, selective Vps34 inhibitor that blocks ATP-dependent class III PI3K activity and PtdIns3P production. Its nanomolar biochemical potency and defined effects on autophagy, vesicle trafficking, and lysosome function make it a useful research tool rather than a standalone indicator of clinical efficacy.

• Tariquidar: Mechanobiology of P-gp Chemoresistance

  2026-08-17

  A high-viscosity tumor microenvironment can increase P-glycoprotein through TRPV4–YAP mechanotransduction, creating a new experimental context for Tariquidar (XR9576). This article shows how selective transporter inhibition can help translational researchers distinguish mechanical regulation of drug resistance from downstream drug efflux.

• Minocycline HCl for Microglial Assays

  2026-08-17

  Minocycline HCl provides a practical pharmacological control for testing whether microglial activity drives retinal amyloid clearance and inflammatory outcomes. This workflow translates 40-Hz flicker findings into reproducible assay design, with preparation guidance, causal controls, and troubleshooting for retinal and neurodegenerative models.

• Alfuzosin Hydrochloride for Reliable Cell Assays

  2026-08-16

  This scenario-based guide explains how Alfuzosin Hydrochloride, SKU A5173, can be incorporated into receptor-focused, viability, proliferation, and cytotoxicity workflows. It connects mechanism, solution preparation, analytical calibration, data interpretation, and vendor selection while distinguishing documented product properties from assay-specific variables that require local validation.

• Camptothecin Workflows for DNA Damage Research

  2026-08-15

  Build reproducible DNA damage, cell-death, autophagy, and adaptive-evolution assays with Camptothecin, a mechanistically defined topoisomerase I inhibitor. This guide connects dose-and-time optimization in cancer models with experimental-evolution concepts from recent prion research while clearly separating established evidence from hypothesis-driven applications.

• Metal-Free Carbon Nanozymes for Sensitive ALP Detection

  2026-08-15

  The reference study develops a metal-free carbon-dot nanozyme assay that converts alkaline phosphatase activity into a colorimetric turn-on signal through pyrophosphate inhibition and enzymatic hydrolysis. Its kinetic analysis shows that pyrophosphate binds at a site distinct from the principal catalytic site, supporting sensitive ALP measurement while reducing metal-related interference.

• RAB Proximity Maps Reveal RAB14 Endosomal Roles

  2026-08-14

  This Communications Biology study uses APEX2 proximity labeling to map proteins neighboring 23 human RAB GTPases, addressing the transient and context-dependent nature of RAB interactions. The dataset identifies functional links involving RAB25, RAB14, the EARP complex, SHIP164, and UHRF1BP1, providing a resource for studying endosomal trafficking and candidate effector recruitment.

451 records 7/31 page Previous Next First page 上5页 678910 下5页 Last page